Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Rapid platelet count improvement in chronic hepatitis C patients with thrombocytopenia receiving direct-acting antiviral agents.

Medicine - 1 May 2020

Chen Yen-Chun, Tseng Chih-Wei, Tseng Kuo-Chih

Abstract excerpt

The effect of direct-acting antiviral agents (DAAs) on short-term platelet improvement in chronic hepatitis C (CHC) patients with thrombocytopenia is unclear.From December 2015 to March 2018, a total of 249 CHC patients receiving DAA treatment with baseline thrombocytopenia (platelet count <150 × 10 /μL) at Dalin Tzu Chi Hospital were enrolled in this retrospective study. Blood examinations were conducted at...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antiviral Agents
Share to Hematologic Tests
Share to Hepatitis C, Chronic

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Liver Cirrhosis

Share to Liver Function Tests

Share to Platelet Count

Share to Sustained Virologic Response

Share to Thrombocytopenia

Source

Open in PubMed Open full text

Identifiers

PMID: 32384505
DOI: 10.1097/MD.0000000000020156
PMCID: PMC7220127

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Rapid platelet count improvement in chronic hepatitis C patients with thrombocytopenia receiving direct-acting antiviral agents.PMID 32384505Read ↗

Efficacy and safety of splenectomy in telaprevir-based triple therapy for chronic hepatitis C patients with thrombocytopenia and advanced fibrosis.Semantic proximity Read ↗

Thrombocytopenia in pegylated interferon and ribavirin combination therapy for chronic hepatitis C.Semantic proximity Read ↗

Hepatitis C virus-associated thrombocytopenia: a controlled prospective, virological study.Semantic proximity Read ↗

Safety and efficacy of partial splenic embolization in telaprevir-based triple therapy for chronic hepatitis C.Semantic proximity Read ↗

Mean Platelet Volume, Red Cell Distribution Width to Platelet Count Ratio, Globulin Platelet Index, and 16 Other Indirect Noninvasive Fibrosis Scores: How Much Do Routine Blood Tests Tell About Liver Fibrosis in Chronic Hepatitis C?Semantic proximity Read ↗

Association of the Low-density Lipoprotein Cholesterol/High-density Lipoprotein Cholesterol Ratio with Glecaprevir-pibrentasvir Treatment.Semantic proximity Read ↗

Worsening of Serum Lipid Profile after Direct Acting Antiviral Treatment.Semantic proximity Read ↗

Increase in platelet count based on inosine triphosphatase genotype during interferon beta plus ribavirin combination therapy.Semantic proximity Read ↗

Safety of local thermal ablation in hepatocellular carcinoma patients with cirrhosis and severe thrombocytopeniaSemantic proximity Read ↗

Anemia and thrombocytosis induced by ribavirin monotherapy in patients with chronic hepatitis C.Semantic proximity Read ↗

Severe thrombocytopenia in a patient with inosine triphosphatase (ITPA)-CC genotype caused by pegylated interferon (IFN)-α-2a with ribavirin therapy: a case report.Semantic proximity Read ↗

Weight loss, leukopenia and thrombocytopenia associated with sustained virologic response to Hepatitis C treatment.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.